| Application no. and date | 01984006.5 (espacenet) (Federated) (European Patent Register), 20011011 | | Patent/reg. no. and date | DK/EP 1325138, 20130717 | | Publication date | 20030709 | | Priority no. and date | US 686497, 20001011 | | EP pub. no. and date |
EP 1325138 20030709 | | Effective date | | | Applicant/owner | Shire Human Genetic Therapies, Inc., 300 Shire Way
Lexington MA 02421, US | | Applicant ref. no. | 13208-9 | | Inventor | Miller, Allan M.,
84 Herrick Road
Boxford, MA 01921, US,
SELDON, Richard F., 106 Bristol Road
Wellesley, MA 02481, US,
TRECO, Douglas S., 87 Brantwood Road
Arlington, MA 02476, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | C07H 21/00 (2006.01) , C07K 14/745 (2006.01) , C12N 15/63 (2006.01) , C12N 15/67 (2006.01) | | Title | OPTIMERET MESSENGER RNA | | Int. application no. | US2001042655 | | Int. publication no. | WO2002064799 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
